MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

COCH — Envoy Medical, Inc. Class A Common Stock

Nasdaq

Envoy Medical, Inc. Class A Common Stock

CompareBack to Screener
$0.68
+0.02(+2.63%)
O
0.68
H
0.70
L
0.65
V
160.58K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About COCH

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

IndustryORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
SectorNot available
IPO DateOct 2, 2023
Employees47
Stock ExchangeNasdaq
Ticker SymbolCOCH

Key Financial Statistics

Market Cap$52.47M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$0.36 - $1.89
52-Week Avg Volume1.06M
VWAP$0.67
Transactions409
Total Recorded Bars755 days